0001104659-19-059439.txt : 20191206 0001104659-19-059439.hdr.sgml : 20191206 20191104153418 ACCESSION NUMBER: 0001104659-19-059439 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20191104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Centogene B.V. CENTRAL INDEX KEY: 0001757097 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: AM STRANDE 7 CITY: ROSTOCK STATE: 2M ZIP: 18055 BUSINESS PHONE: 49 30 2130 00325 MAIL ADDRESS: STREET 1: AM STRANDE 7 CITY: ROSTOCK STATE: 2M ZIP: 18055 FORMER COMPANY: FORMER CONFORMED NAME: Centogene B.V. DATE OF NAME CHANGE: 20181025 CORRESP 1 filename1.htm

 

November 4, 2019

 

 

Division of Corporation Finance
U.S. Securities and Exchange Commission

100 F Street, N.E.
Washington, D.C. 20549-3628

 

Attn:

Mr. Jonathan Burr
Ms. Pamela Howell
Ms. Brigitte Lippmann

 

Re:

Centogene B.V.
Registration Statement on Form F-1
Registration No. 333-234177

 

Dear Mr. Burr, Ms. Howell and Ms. Lippmann:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Daylight Time on November 6, 2019 or as soon thereafter as is practicable. By separate letter, the underwriters of the issuance of the securities being registered join in this request for acceleration.

 

Please do not hesitate to contact Leo Borchardt of Davis Polk & Wardwell London LLP at +44 20 7418 1334 with any questions or comments with respect to this letter.

 

Sincerely,

 

CENTOGENE B.V.

 

 

 

By:

/s/ Arndt Rolfs

 

 

Name: Arndt Rolfs

 

 

Title:   Chief Executive Officer

 

 

Via EDGAR

 

CC: Leo Borchardt, Davis Polk & Wardwell London LLP